Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry

Clinical and Experimental Neuroimmunology · Published 2025-08-17 · DOI 10.1111/cen3.70017

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1111/cen3.70017

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles